Who is the CEO of Merck and Co?
Robert M. Davis (Jul 1, 2021–)
Merck & Co./CEO
Pharmaceutical giant Merck, which boasts some of the world’s best-selling drugs, has a new CEO to lead the company. Robert Davis became chief executive officer of Merck on Thursday, one day after former CEO Ken Frazier retired.
What does the CEO of Merck make?
What is the salary of Kenneth Frazier? As the Chairman of the Board, President, and Chief Executive Officer of Merck & Co Inc, the total compensation of Kenneth Frazier at Merck & Co Inc is $27,648,500.
What did Kenneth Frazier do?
After joining Merck & Co. as general counsel, he directed the company’s defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company (part of the Fortune 500 companies)….
| Kenneth Frazier | |
|---|---|
| Occupation | Executive Chairman, Merck & Co. |
How old is Merck CEO Ken Frazier?
66 years (December 17, 1954)
Kenneth C. Frazier/Age
Frazier, 66, will be succeeded as CEO on June 30 by Chief Financial Officer Robert Davis and will continue to serve on Merck’s board as executive chairman “for a transition period to be determined by the board,” the company said.
Is the CEO of Merck black?
He is one of only 4 Black CEOs in the Fortune 500, and famously stood up to Trump over Charlottesville in 2017. Merck CEO Kenneth Frazier said Thursday he’s stepping down to serve on the board as executive chairman. Frazier, 66, is one of only four Black CEOs on the Fortune 500.
Where is Merck headquarters?
Kenilworth, New Jersey, United States
Merck & Co./Headquarters
Is Merck a US company?
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada, Merck & Co. was established as an American affiliate in 1891.
What is Alex Gorsky salary?
$25,365,800
What is the salary of Alex Gorsky? As the Chairman of the Board and Chief Executive Officer of Johnson & Johnson, the total compensation of Alex Gorsky at Johnson & Johnson is $25,365,800.
Who is president of Merck?
Kenneth C. Frazier
Kenneth C. Frazier is the Executive Chairman of Merck’s board of directors, a role he began in July 2021, following his retirement from a decade-long tenure as Merck’s President and Chief Executive Officer.
Is Kenneth Frazier married?
Andrea Frazier
Kenneth C. Frazier/Spouse
What companies does Merck own?
It has acquired Kelco, Calgon, Charles E Frosst & Co and Aircoil, with its largest takeover occurring in 2009, when it completed a reverse acquisition of Schering-Plough for $US41 billion. It currently resides at 170 on the Forbes Global 2000, an annual list of the world’s richest public companies.
What is Merck known for?
Merck & Co. manufactures a variety of well-known pharmaceutical drugs, vaccines and animal-health products. It made the first smallpox vaccine for commercial use in the U.S. It is also the maker of the painkiller Vioxx and the HPV vaccine Gardasil.
Who is going to be the new CEO of Merck?
Frazier, who will be succeeded as CEO by the company’s chief financial officer, will become executive chairman for an undetermined period of time when the transition occurs at the end of June.
How many employees does the Merck Group have?
Number of employees. The Merck Group, branded and commonly known as Merck, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries.
Who was the founder of Merck and co?
1668 – Friedrich Jacob Merck acquires the Angel Pharmacy, which became the heart of Merck (and is still owned by the Merck family today). 1891 – Merck in Germany became Merck KGaA or “German Merck” and a United States subsidiary called Merck & Co., Inc. was established in New Jersey.
What did Kenneth Frazier do as Merck CEO?
Under his leadership, the company delivered Keytruda, a cancer drug that made up more than one-third of Merck’s pharmaceutical revenue in 2020. There have also been disappointments under his tenure. Most recently, the company abandoned its COVID-19 vaccine candidate after a clinical trial delivered underwhelming results.